There are 2789 resources available
255P - Propreseer: A reliable, collaborative prognostic model for tamoxifen-resistance breast cancer
Presenter: Weiqi Nian
Session: ePoster Display
Resources:
Abstract
256P - PI3K mutation is associated with reduced sensitivity to CDK4/6 inhibitors in metastatic breast cancer
Presenter: Keechilat Pavithran
Session: ePoster Display
257P - Health-related quality of life (HRQoL) in the ASCENT study of sacituzumab govitecan (SG) in metastatic triple-negative breast cancer (mTNBC)
Presenter: Sibylle Loibl
Session: ePoster Display
259P - Weekly ladiratuzumab vedotin monotherapy for metastatic triple-negative breast cancer
Presenter: Michaela Tsai
Session: ePoster Display
260P - High enrichment of ATRX mutations in lung and liver metastasis of breast cancer
Presenter: Rongrong Chen
Session: ePoster Display
262P - Pattern of failure and treatment results in triple-negative breast cancer patients
Presenter: Sherif Farouk El Zawawy
Session: ePoster Display
87P - Clinical development of a predictive biomarker with 58 tumor genes for dovitinib treatment of solid tumors
Presenter: Roberto Pili
Session: ePoster Display
88P - Efficacy of olaparib in advanced cancers occurring in patients with germline or somatic tumor mutations in homologous recombination (HR) genes, a Belgian Precision phase II basket study
Presenter: Sofie Joris
Session: ePoster Display